Related Experiment Videos
Structure-function relationships of the dietary anticarcinogen ellagic acid
D H Barch1, L M Rundhaugen, G D Stoner
1Department of Medicine, Lakeside Veterans Affairs Medical Center, Northwestern University Medical School, Chicago, IL 60611, USA.
Abstract:
Ellagic acid is a complex planar molecule which demonstrates a variety of anticarcinogenic activities. Ellagic acid has been shown to inhibit the CYP1A1-dependent activation of benzo[a]pyrene; to bind to and detoxify the diolepoxide of benzo[a]pyrene; to bind to DNA and reduce the formation of O6-methylguanine by methylating carcinogens; and to induce the phase II detoxification enzymes glutathione S-transferase Ya and NAD(P)H:quinone reductase. Chemical analogs of ellagic acid were synthesized to examine the relationship between the hydroxyl and lactone groups of the ellagic acid molecule and its different anticarcinogenic activities. These studies demonstrated that both the 3-hydroxyl and the 4-hydroxyl groups were required for ellagic acid to directly detoxify the diolepoxide of benzo[a]pyrene, while only the 4-hydroxyl groups were necessary for ellagic acid to inhibit CYP1A1-dependent benzo[a]pyrene hydroxylase activity. Induction of glutathione S-transferase Ya and NAD(P):quinone reductase required the lactone groups of ellagic acid, but the hydroxyl groups were not required for the induction of these phase II enzymes. In addition, the lactone groups, but not the hydroxyl groups, were required for the analogs to reduce the carcinogen-induced formation of O6-methylguanine. Thus, different portions of the ellagic acid molecule are responsible for its different putative anticarcinogenic activities.
Insights
Ellagic acid exhibits diverse anticancer effects by detoxifying carcinogens and boosting detoxification enzymes. Different molecular parts, including hydroxyl and lactone groups, are crucial for its specific anticarcinogenic activities.
Area of Science:
- Natural Products Chemistry
- Cancer Chemoprevention
- Molecular Toxicology
Background:
- Ellagic acid is a natural compound with demonstrated anticarcinogenic properties.
- It modulates carcinogen metabolism and DNA damage pathways.
- Understanding structure-activity relationships is key to optimizing its therapeutic potential.
Purpose of the Study:
- To investigate the specific roles of hydroxyl and lactone groups in ellagic acid's anticarcinogenic activities.
- To correlate structural features with inhibition of carcinogen activation and induction of detoxification enzymes.
- To guide the design of novel chemopreventive agents.
Main Methods:
- Synthesis of chemical analogs of ellagic acid.
- Assays for CYP1A1-dependent benzo[a]pyrene hydroxylase activity.
- Measurement of direct detoxification of benzo[a]pyrene diolepoxide.
- Quantification of O6-methylguanine formation.
- Assessment of glutathione S-transferase Ya and NAD(P)H:quinone reductase induction.
Main Results:
- Both 3- and 4-hydroxyl groups are essential for detoxifying benzo[a]pyrene diolepoxide.
- The 4-hydroxyl group alone inhibits CYP1A1-dependent benzo[a]pyrene hydroxylase activity.
- Lactone groups, not hydroxyl groups, are required for inducing phase II detoxification enzymes.
- Lactone groups are also necessary for reducing carcinogen-induced O6-methylguanine formation.
Conclusions:
- Different functional groups of ellagic acid mediate distinct anticarcinogenic mechanisms.
- Hydroxyl groups are critical for direct carcinogen detoxification and metabolism inhibition.
- Lactone groups are essential for inducing phase II enzymes and preventing DNA adducts.
- Structure-activity relationship studies provide insights for developing targeted chemopreventive strategies.